DVI, Inc. Announces Memorandum of Understanding with De Lage Landen.

Business Editors/Health/Medical Writers

JAMISON, Pa.--(BUSINESS WIRE)--April 30, 2003

DVI, Inc. (NYSE:DVI), an independent healthcare financier, announced today that it has signed a Memorandum of Understanding with De Lage Landen, a global provider of vendor finance programs to manufacturers and distributors of capital goods and services, with a view to forming a joint venture company to operate in the Asia/Pacific region.

It is anticipated that the joint venture company will commence operation in July 2003 and will focus exclusively on providing medical equipment financing throughout the Asia/Pacific region.

DVI will combine its established presence in the Asia/Pacific region, specialized knowledge and extensive relationships with medical equipment manufacturers with De Lage Landen. This is a wholly owned subsidiary of the global Netherlands based "AAA" rated Rabobank will bring vendor finance expertise in Healthcare thereby offering DVI the opportunity to provide its customers with comprehensive solutions.

Michael A. O'Hanlon, President and Chief Executive Officer of DVI, commented that the joint venture will be well positioned to take advantage of the emerging opportunities throughout the region.

De Lage Landen is an international provider of high-quality asset based financing products. The company, headquartered in Eindhoven, the Netherlands, has offices in 20 countries throughout Europe, the Americas, Australia and New Zealand.

De Lage Landen specializes in asset financing and vendor finance programs internationally, with a focus on the following industries: Agriculture & Food, Healthcare, Office Equipment, IT, Telecommunications and Material Handling & Construction Equipment. Domestically a broad range of leasing and trade finance services are distributed via local Rabobanks and directly to the market.

In 2002, De Lage Landen grew its net profit to $94 million and its balance sheet total to $12.9 billion. Additional information is available at www.delagelanden.com.

DVI is an independent specialty finance company for healthcare providers worldwide with $2.7 billion of managed net financed assets. The Company extends loans and leases to finance the purchase of diagnostic and other therapeutic medical equipment directly and through vendor programs. DVI also offers lines of credit for working capital backed by healthcare receivables in the United States.

Additional information is available at www.dvi-inc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that are not historical facts are forward-looking statements. Such statements are based upon many important factors, many of which may be outside the Company's control, causing actual results to differ materially from those suggested.

Such factors include, but are not limited to, legislative and regulatory changes in general, including such changes affecting the healthcare industry, demand for DVI's services, pricing, market acceptance, fluctuations in interest rates and foreign currency exchange rates, general economic conditions, litigation, competition, capital markets conditions, the ability to complete funding transactions, and other risks identified in the Company's filings with the Securities and Exchange Commission.